Login/Register

B2B

Be Balanced supplement (probiotic) 30caps

30caps
Product SKU: 000134 Categories: , Label:
Bacillus coagulans (or Lactobacillus sporogenes) and Bacillus subtilis are two spore-forming probiotic bacteria. Some of their benefits: -According to FAO (Food and Agriculture Organization of the United Nations) and WHO (World Health Organization), probiotics are “live microorganisms which, when administered in adequate amounts, confer a health benefit on the host”. -Probiotics must be able to survive through the gastrointestinal tract (which means in an acidic environment and in the presence of bile salts and digestive enzymes), in order to reach and colonize the gut and proliferate. -Probiotic bacteria are safe for human consumption providing a variety of beneficial effects on the host, such as the regulation and maintenance of the gut’s physiological microbiota and the balance of the gut’s homeostasis, the inhibition of pathogens’ and other harmful microorganisms’ colonization and growth, the stabilization of the gastrointestinal tract’s function, the stimulation of immune responses, etc. -They are administered either as a preventive measure or as a therapeutic agent. -Nowadays, spore-forming probiotics, especially of the genus Bacillus, are widely used in humans as dietary supplements. -They are more tolerant to the environmental conditions of the digestive tract and unlike other probiotic bacteria, the entire administered dose of bacilli reaches the small intestine tract without loss. -Moreover, they have the ability to produce anti-microbial substances (bacteriocins), that suppress the growth of intestinal pathogens and other competitive micro-organisms and contribute to the overall better functioning of the intestine even in cases of disorders such as the Irritable Bowel Syndrome (IBS). -Bacillus coagulans and B. subtilis strains have been reported as “safe” by the European Union Food Safety Authority-EFSA (QPS system-Qualified Presumption of Safety) and the U.S. Food and Drug Administration-FDA (GRAS-Generally Recognized Αs Safe). -Bacillus coagulans has been found to be effective against acute diarrhea and abdominal discomfort, but also effective in the management of the clinical symptoms and the depression of IBS patients. -As for Bacillus subtilis, it contributes to the maintenance of the healthy gut microbiota and the stimulation of elderly people’s immune responses.

Login to view prices

  • Contributes to the balance of the intestinal flora.
  • Maintains good bowel function.
Formulated with: Lactobacillus sporogenes, Bacillus subtilis, dicalcium phosphate, microcrystalline cellulose, hydroxypropylmethylcellulose, magnesium stearate, precipitated silica
Formulated WITHOUT: preservatives, fragrances, sweeteners, pigments

EOF Notification number: 136275/24-12-2020
The product is not subject to authorization.

NUTRIENT COMPOSITION

Daily dose (1-2 capsules)
  • Probiotic Lactobacillus sporogenes – 15 billion/g: 33.35 mg – 66.67 mg (number of seeds: 0.5 billion – 1 billion)
  • Probiotic Bacillus subtilis – 100 billion/g: 25 mg – 50 mg (number of seeds: 2.5 billion – 5 billion)
Consume 1-2 capsules per day with water or juice. For administration to children, it is advisable to open the capsule and take it directly through the mouth or dilute it in liquid (milk or fruit juice) and administer within half an hour.
  • Do not use in the event of hypersensitivity to any of the ingredients.
  • Do not exceed the recommended daily dose.
  • Food supplements should not be used as a substitute for a balanced diet.
  • Keep out of reach of children.
  • This product is not intended for the prevention, treatment or cure of human disease.
  • Consult your doctor if you are pregnant, breastfeeding, undergoing pharmaceutical treatment or experiencing health problems.
  • Store the product in a cool and dry area, away from heat sources and protected from light.
  • The expiration date stated on the product refers to intact packaging, kept under proper storage conditions.
FAO (2001). Health and Nutrition Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria: report of a joint FAO/WHO expert consultation, Cordoba, Argentina, 1-4 October 2001. Elisashvili, V., Kachlishvili, E., & Chikindas, M.L. (2019). Recent Advances in the Physiology of Spore Formation for Bacillus Probiotic Production. Probiotics and Antimicrobial Proteins, 11 (3): 731-747. https://doi.org/10.1007/s12602-018-9492-x Catinean, A., Neag, A.M., Nita, A., Buzea, M., & Buzoianu, A.D. (2019). Bacillus spp. Spores-A Promising Treatment Option for Patients with Irritable Bowel Syndrome. Nutrients, 11 (9): 1968. https://doi.org/10.3390/nu11091968 Konuray, G., & Erginkaya, Z. (2018). Potential Use of Bacillus coagulans in the Food Industry. Foods, 7 (6): 92. https://dx.doi.org/10.3390%2Ffoods7060092 Soman, R.J., & Swamy, M.V. (2019). A prospective, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of SNZ TriBac, a three-strain Bacillus probiotic blend for undiagnosed gastrointestinal discomfort. International Journal of Colorectal Disease, 34 (11): 1971-1978. https://doi.org/10.1007/s00384-019-03416-w Maity, C., & Gupta, A.K. (2019). A prospective, interventional, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Bacillus coagulans LBSC in the treatment of acute diarrhea with abdominal discomfort. European Journal of Clinical Pharmacology, 75 (1): 21-31. doi: 10.1007/s00228-018-2562-x Majeed, M., Nagabhushanam, K., Natarajan, S., Sivakumar, A., Ali, F., Pande, A., Majeed, S. & Karri, S.K. (2016). Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study. Nutrition Journal, 15: 21. https://doi.org/10.1186/s12937-016-0140-6 Majeed, M., Nagabhushanam, K., Arumugam, S., Majeed, S., Ali, F. (2018). Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study. Food & Nutrition Research, 62: 1218. https://doi.org/10.29219/fnr.v62.1218 Hatanaka, M., Yamamoto, K., Suzuki, N., Iio, S., Takara, T., Morita, H., Takimoto, T., & Nakamura, T. (2018). Effect of Bacillus subtilis C-3102 on loose stools in healthy volunteers. Beneficial Microbes, 9 (3): 357-365. https://doi.org/10.3920/bm2017.0103 Lefevre, M., Racedo, S.M., Ripert, G., Housez, B., Cazaubiel, M., Maudet, C., Justen, P., Marteau, P., & Urdaci, M.C. (2015). Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study. Immunity & Ageing, 12: 24. https://doi.org/10.1186/s12979-015-0051-y

SIMILAR PRODUCTS

Are you interested in learning more information?

Unlock business potential! Contact us today to upgrade your business or register.

CONTACT
REGISTER

INFORMATION

PAYMENT METHODS

SHIPPING METHODS

PRESS KIT

CONTACT

USEFUL - DOWNLOADS

B2B COLLABORATION POLICY

COMPANY PRESENTATION

NEWSLETTER

FOLLOW

FACEBOOK

INSTAGRAM

TIK TOK

YOUTUBE

LINKEDIN

ACCOUNT

LOGIN

REGISTER

TERMS & CONDITIONS

PRIVACY POLICY

© 2025 PHYSIS LABORATORY